Expert Interviews

Cervical Cancer Screening Best Practices for Physicians
May 09, 2025

An interview with Jeff Andrews, MD, FRCSC, of BD Life Sciences.

Understanding Gaps in Patient Knowledge of Cervical Cancer Screening
May 08, 2025

An interview with Jeff Andrews, MD, FRCSC, of BD Life Sciences.

Cervical Cancer Screening: What Physicians Can Do To Convince Patients
May 07, 2025

An interview with Jeff Andrews, MD, FRCSC, of BD Life Sciences.

Foluso Fakorede, MD: Racial Disparities in PAD Amputation Rates
May 06, 2025

Rates of amputation in Black Americans with peripheral arterial disease are 3-times higher than that of their White counterparts. Dr Fakorede, discusses, here.

Stool-Based Testing for Colorectal Cancer Screening is On the Rise: Expert Perspective with Mark Fendrick, MD
May 06, 2025

The increase in stool-based CRC testing is a logical trend, Hendrick said in an interview, given the convenience plus the 2 million younger adults now eligible for screening.

Identifying HPV Types: Preventing Over Treatment and Under Treatment
May 06, 2025

An interview with Jeff Andrews, MD, FRCSC, of BD Life Sciences.

BD Onclarity Added to ASCCP Guidelines: What It Means
May 05, 2025

An interview with Jeff Andrews, MD, FRCSC, of BD Life Sciences.

Marschall Runge, MD PhD, Shares Thoughts on the Trajectory of Measles in the US
May 05, 2025

Measles, declared eradicated in the US 25years ago, has infected 900 Americans and is responsible for 3 deaths of children younger than age 5. How did we get here?

PAD Risk Amplifiers and Screening Strategies: A Talk with Foluso Fakorede, MD
May 02, 2025

ACP 2025: Dr Fakorede outlines PAD risk amplifiers, polyvascular disease connections, and when to screen using ABI, TBI, or exercise testing in high-risk patients.

The Role of Extended HPV Genotyping In Managing High Risk Patients
May 02, 2025

An interview with Jeff Andrews, MD, FRCSC, of BD Life Sciences.